CN Stock MarketDetailed Quotes

603520 Zhejiang Starry Pharmaceutical

Watchlist
  • 11.03
  • -0.14-1.25%
Not Open Apr 18 15:00 CST
3.78BMarket Cap-67256P/E (TTM)

About Zhejiang Starry Pharmaceutical Company

The company was founded in 1997. During the “12th Five-Year Plan” period, the company extended to the front end and end of the industrial chain. It established an intermediate production base in Zhangshu, Jiangxi in January 2011 - Jiangxi Sitaili Pharmaceutical Co., Ltd., and established a pharmaceutical factory in Jinshan, Shanghai - Shanghai Sitaili Pharmaceutical Co., Ltd. in June 2012. On March 9, 2016, the company was listed on the Shanghai Stock Exchange, stock code: 603520. In November 2018, the company successfully acquired Zhejiang Taizhou Poseidon Pharmaceutical Co., Ltd., a domestic peer, and entered the fast track of rapid development. The company's main products are a series of nonionic iodine contrast agent drugs. The company's main products: iohexol injections, iopaxanol injections, iodoxanol injections, iohexanol, iodoxanol, iophorol, iodopromide, iopromide, iodobuxacin, gadobulol, etc., levofloxacin, levofloxacin hydrochloride, raw materials and intermediates, CIBA, OPAA, 3N, ILC, JSQ, iodine substitutes, azoprofen sodium, etc. The company is a high-tech enterprise. It has undertaken many national and provincial research projects, successfully completed the acceptance of results, and obtained a number of certificates. The “non-ionic X-CT contrast agent raw material - iohexol” project undertaken by the company obtained the “National Torch Program Project Certificate” issued by the Torch High-tech Industry Development Center of the Ministry of Science and Technology of the People's Republic of China. Iohexol was also rated as a “Zhejiang High-tech Product” by the Zhejiang Provincial Science and Technology Department, and as a “Taizhou Famous Brand Product” by the Taizhou Famous Brand Product Certification Committee. The “Synthesis Process Development and Industrialization of High Purity Non-ionic X-CT Contrast Agent-Iohexol” project was awarded the “Zhejiang Science and Technology Second Prize” and the “Taizhou Science and Technology Progress Award” by the Zhejiang Provincial People's Government and the Taizhou Municipal People's Government respectively.

Company Profile

Short Name-A司太立
Symbol-A603520
Company NameZhejiang Starry Pharmaceutical Co., Ltd.
Listing DateMar 9, 2016
Issue Price12.15
Shares Offered30.00M share(s)
FoundedSep 15, 1997
Listed ExchangeSH Stock Exchange
Legal Representativejian hu
CEOweiyi shen
Secretarychao sun
Accounting FirmTianjian Certified Public Accountants (Special General Partnership)
Legal CounselBeijing Jincheng Tongda Law Firm
Employees855
Phone0576-87718605
Office AddressNo. 9 Fengxi West Road, Modern Industrial Agglomeration Area, Xianju County, Zhejiang
Zip Code317306
Registered AddressNo. 1, Sitaili Avenue, Modern Industrial Agglomeration Area, Xianju County, Taizhou City, Zhejiang Province
Fax0576-87718686
Emailstl@starrypharma.com
Business License331000400001749
BusinessManufacture and sale of pharmaceutical intermediates; operates the export business of the company's own products and the import business of machinery, equipment, spare parts, and raw and auxiliary materials required by the enterprise, with the exception of goods and technologies restricted by the company or prohibited from being imported or exported by the country. Manufacture of APIs (iodothyol, iodoxalol, iodopanol, iodofol, levofloxacin hydrochloride, levofloxacin, pazufloxacin mesylate); (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • jian hu
  • Chairman,directors
  • 975.00K
  • weiyi shen
  • Vice Chairman,directors,general manager
  • 569.60K
  • gang xu
  • directors
  • --
  • jinsheng hu
  • directors
  • --
  • meiying mao
  • Independent directors
  • --
  • xiaoke zhang
  • Independent directors
  • --
  • jiming hu
  • Independent directors
  • --
  • chao sun
  • Board Secretary
  • 274.20K
  • fangwei zheng
  • Chairman of the Supervisory Board,Employee supervisors
  • 125.90K
  • hongfei zhang
  • auditors
  • --
  • lingqiao li
  • auditors
  • 269.50K
  • chun ye
  • Deputy General Manager
  • --
  • chaoyang yao
  • Deputy General Manager
  • --
  • junfeng guo
  • Chief Financial Officer
  • 235.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg